Clinically Isolated Syndrome (CIS) Market is segmented By Treatment (Systemic Treatments, Primary Th...
Market Size in USD Bn
CAGR6.9%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 6.9% |
Market Concentration | High |
Major Players | NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Siemens Healthcare Private Limited, Natus Medical Incorporated and Among Others |
The clinically isolated syndrome (CIS) market is estimated to be valued at USD 17.14 Bn in 2025 and is expected to reach USD 27.34 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032. The market is driven by rising prevalence of multiple sclerosis and growing awareness about early diagnosis and treatment of the CIS condition to delay progression to multiple sclerosis.